Evonetix Ltd, a synthetic biology company bringing semiconductor technology to DNA synthesis, has completed a $24 million financing round, extending its total series B funding to over $54 million.
This fundraise was led by existing investor Foresite Capital, with Molten Ventures,…
Source: www.labiotech.eu – Read more



